baber/WOPTO huggingface dataset:
Patent AU-2004322955-B2 (AU)
Title: Storage of natural gas in liquid solvents and methods to absorb and segregate natural gas
Inventor: AGNEW PATRICK A
IPC: F17C11/00
Filed: 2004-10-27
Granted: 2011-08-11
Abstract: Bulk storage of natural gas or methane is facilitated by absorbing gas in a liquefied medium. Systems and processes are provided that facilitate the absorption of natural gas or methane into a liquid or liquid vapor medium for storage and transport, and back into a gas for delivery to market. In a preferred embodiment, the absorptive properties of ethane, propane and butane under moderate conditions of temperature and pressure are utilized to store natural gas or methane at more efficient levels of compressed volume ratio. The preferred mixing process efficiently combines natural gas or methane with a solvent medium such as liquid ethane, propane, butane, or other suitable fluid, to form a concentrated liquid or liquid vapor mixture suited for storage and transport. The solvent medium is preferably recycled in the conveyance vessel on unloading of the natural gas.
Patent AU-2005212496-B2 (AU)
Title: A culture medium for the production of filamentary fungi
Inventor: PANCHAUD-MIRABEL ELISABETH
IPC: C12N1/14
Filed: 2005-02-08
Granted: 2010-09-23
Abstract: A culture medium for filamentary fungi comprising at least one carbon source chosen from the group consisting of molasses, malt extract and sucrose and at least one organic nitrogen source chosen from yeast extract and corn steep liquor is described; a method for producing filamentary fungi, in particular nematophagus fungi on an industrial scale, comprising the step of seeding conidia of such fungi in the aforementioned culture medium and maintaining such a culture medium at a temperature of 23-30 DEG C for a time of 5-10 days to determine the reproduction and growth of the fungi is also described.
Patent AU-2005232671-B2 (AU)
Title: Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability
Inventor: GREENQUIST MATTHEW
IPC: A61K9/16
Filed: 2005-04-06
Granted: 2011-03-17
Abstract: Comestible materials encapsulated by a film-forming composition including a plant protein source and methods of forming the same are provided. The film-forming composition affects the site of digestion of the comestible material within the digestive tract of an animal or a human thereby allowing the material to be most effectively utilized by the body. Also, the film-forming compositions may be used to enhance the stability of the encapsulated material and prevent undesired interaction with other components of a mixture.
Patent AU-2005237167-B2 (AU)
Title: Method and system for providing notification when a user becomes available for communicating
Inventor: RAGHAV AMRITANSH
IPC: G06F17/00
Filed: 2005-11-25
Granted: 2011-03-17
Abstract: A method and system for providing notifications of changes in the presence state of contacts is provided. A notification system allows a user to specify those contacts of interest for whom the user wants to be notified when the contact enters a certain presence state. When presence information is received about a contact, the notification system determines whether the contact is a contact of interest as specified by the user. If so, then the notification system determines whether the presence information indicates a change in presence state that is of interest to the user. If the contact and the change in presence state are of interest to the user, the notification system notifies the user.
Patent AU-2005244012-B2 (AU)
Title: Prolongation of survival of an allograft by inhibiting complement activity
Inventor: ROTHER RUSSELL P
IPC: A61K39/395
Filed: 2005-05-16
Granted: 2011-08-18
Abstract: Methods of prolonging survival of allotransplanted cells, tissues or organs are presented. These methods are directed to administering to the allotransplant recipient an inhibitor of complement activity together with one or more immunosuppressants. The inhibitor of complement activity is administered chronically. These methods have been determined to aid in preventing chronic rejection of allografts. These methods can additionally be used in cases in which the recipient has been presensitized to the allograft or in which there is an ABO mismatch between the allograft and the recipient.
Patent AU-2005296759-B2 (AU)
Title: Improved COD abatement process for electrochemical oxidation
Inventor: GRANGE DIDIER CARLE GASTON
IPC: C02F1/467
Filed: 2005-10-18
Granted: 2010-02-25
Abstract: The invention relates to an effluent COD treatment procedure by anodic oxidation combining the use of two different types of anode with a suitable apportionment of current. The first type of anode comprises an anode based on diamond doped-synthetic diamond. The second type of anode comprises an anode with high oxygen overvoltage containing tin and antimony oxides.
Patent AU-2005337168-B2 (AU)
Title: Phosphate biosensors and methods of using the same
Inventor: GU HONG
IPC: C07H21/02
Filed: 2005-10-14
Granted: 2012-07-05
Abstract: Phosphate biosensors are disclosed, which comprise a phosphate binding domain conjugated to donor and fluorescent moieties that permit detection and measurement of Fluorescence Resonance Energy Transfer upon phosphate binding. Such biosensors are useful for real time monitoring of phosphate metabolism in living cells.
Patent AU-2006232673-B2 (AU)
Title: Dynamic method for visual rendering of data display and input windows on a computer screen
Inventor: RICHARD MOLENAAR
IPC: G06F17/30
Filed: 2006-03-29
Granted: 2011-10-13
Abstract: The invention concerns a method for visual rendering of data display and input windows on a computer screen. The windows are opened with a browser by a remote Web site user. In response to a request emitted by the user's browser the site returns thereto, via the network whereon they are connected, a generic form of the requested page not including any pre-positioning information. The browser, during a brief display of the generic form of the page, captures the dimensions of the displayed elements, calculates new display widths and redimensions the elements. Thereafter, the browser displays permanently the page whereof the elements have been adjusted to obtain a good visual rendering. The generic form of the page can therefore be defined independently of the user's display means and in particular does not require using a table for positioning the elements to be displayed.
Patent AU-2006238686-B2 (AU)
Title: Pyrrolobenzodiazepines
Inventor: ZHIZHI CHEN
IPC: A61P35/00
Filed: 2006-04-21
Granted: 2011-10-06
Abstract: Compounds of the formula: (I) or solvate thereof, wherein: R is an optionally substituted C aryl group; R and R are independently selected from H, R, OH, OR, SH, SR, NH, NHR, NRR', nitro, MeSn and halo; where R and R' are independently selected from optionally substituted C alkyl, C heterocyclyl and C aryl groups; R is selected from H, R, OH, OR, SH, SR, NH, NHR, NHRR', nitro, MeSn and halo; R" is a Calkylene group, which chain may be interrupted by one or more heteroatoms and/or aromatic rings; X is selected from O, S, or NH; z is 2 or 3; M is a monovalent pharmaceutically acceptable cation; R', R', R', R', X' and M' are selected from the same groups as R, R, R, R, X and M respectively, or M and M' may together represent a divalent pharmaceutically acceptable cation.
Patent AU-2006244445-B2 (AU)
Title: Anti-CD19 antibody therapy for autoimmune disease
Inventor: GRON HANNE
IPC: A61K51/00
Filed: 2006-05-05
Granted: 2013-04-18
Abstract: The invention relates to immunotherapeutic compositions and methods for the treatment of autoimmune diseases and disorders in human subjects using therapeutic antibodies that bind to the human CD 19 antigen and that preferably mediate human ADCC. The present invention relates to pharmaceutical compositions comprising human or humanized anti-CD 19 antibodies of the IgGl or IgG3 human isotype. The present invention relates to pharmaceutical compositions comprising human or humanized anti- CD 19 antibodies of the IgG2 or IgG4 human isotype that preferably mediate human ADCC. The present invention also relates to pharmaceutical compositions comprising chimerized anti-CD19 antibodies of the IgGl, IgG2, IgG3, or IgG4 isotype that mediate human ADCC. In preferred embodiments, the present invention relates to pharmaceutical compositions comprising monoclonal human, humanized, or chimeric anti-CD 19 antibodies.
Patent AU-2006257558-B2 (AU)
Title: Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof
Inventor: LUPING ZHANG
IPC: C07C219/24
Filed: 2006-06-16
Granted: 2012-01-12
Abstract: Compounds of the general formula (I), optical isomers, pharmaceutically acceptable salts, preparation process and uses thereof in which R1, R2, R3 and R4 are as defined in specification are disclosed. Such compounds can be optical isomers or racemic mixtures and can be metabolically transformated into 1-[2-dimethylamine-1-(4-hydroxyphenyl)-ethyl]cyclohexanol with new pharmaceutically active in vivo after administration, which can be used for treating diseases associated central nervous system such as depression et al. by interrupting reuptake of 5-hydroxytryptamine (5-HT ) and norepinephrine (NA ) .
Patent AU-2006325613-B2 (AU)
Title: Breathing assistance apparatus
Inventor: KRAMER MARTIN PAUL FRIEDERICH
IPC: A61L2/06
Filed: 2006-12-15
Granted: 2012-01-19
Abstract: The present invention provides a breathing assistance apparatus that has a convenient and effective method of cleaning internal conduits inside the apparatus. The breathing assistance apparatus is preferably a gases supply and humidification device. The cleaning method is a method of disinfection that is automated so minimal training is required to disinfect in particular an internal elbow conduit within the device. It is therefore not necessary to dismantle the gases supply and humidification device, therefore, inadvertent damage to the internal parts of the device is avoided. The present invention also provides a method of disinfecting a heated breathing conduit and a patient interface.
Patent AU-2007200760-B2 (AU)
Title: Non-invasive pressure measurement in a fluid adjustable restrictive device
Inventor: DLUGOS DANIEL F
IPC: A61B17/12
Filed: 2007-02-20
Granted: 2013-01-24
Abstract: An implantable restriction device is configured to provide a restriction in a patient as a function of the pressure of fluid. The implantable restriction device includes one or more pressure sensors configured to sense pressure of the fluid within the implantable restriction device. Pressure data obtained by the one or more pressure sensors may be communicated to a device located external to the patient, which may process the pressure data, and may further provide a display to a user including information relating to the processed pressure data. Where the implantable restriction device comprises an adjustable gastric band, the one or more pressure sensors may be located in any number of the following locations: an injection port, an interface between the injection port and a catheter, in a catheter, in-line with a catheter, adjacent to a catheter, in a gastric band, in a gastric band buckle, or elsewhere. 30 -* 36
Patent AU-2007203372-B2 (AU)
Title: Universal collection medium
Inventor: LORINCZ ATTILA T
IPC: C12M1/34
Filed: 2007-07-19
Granted: 2011-02-03
Abstract: This invention provides a novel universal collection medium for cell collection. The medium allows for the first time the ability to perform cytology and direct molecular analysis on cells preserved in a single sample. This invention also provides novel methods for analyzing cells to assess human conditions.
Patent AU-2007227262-B2 (AU)
Title: Method and apparatus for recovering and transporting methane gas
Inventor: SCHIMP CHRISTOPHER E
IPC: E21B43/00
Filed: 2007-03-21
Granted: 2012-08-23
Abstract: This invention relates to the field of the recovery of methane gas from a coal mine and conventional Natural Gas. More particularly, it involves an apparatus and method for economically recovering methane gas from a coal mine and transporting the methane gas to an end user or other location. The invention further provides an apparatus and method for economically recovering Natural Gas that is stranded due to high impurities that requires processing and/or Natural Gas that is not located near a pipeline. According to a first preferred embodiment of the invention, such methods for recovering and transporting gas comprise (a) transferring gas from a producing well to a first subterranean capacitor and storing the gas in said capacitor and (b) transferring gas from the first subterranean capacitor to a second subterranean capacitor, a pipeline, an end user, a gas processor, or a power plant.
Patent AU-2007231265-B2 (AU)
Title: Cosmetic active ingredient composed of arginine ferrulate and a microalgae extract and its uses
Inventor: MEKIDECHE NICOLE
IPC: A61K8/97
Filed: 2007-03-27
Granted: 2012-03-15
Abstract: The invention relates to a novel cosmetic active ingredient composed of a microalgae extract and arginine ferrulate, its uses for activating proteasome and the production of thioredoxin, a cosmetic composition containing it and the use of such a cosmetic composition for combating skin ageing.
Patent AU-2007247040-B2 (AU)
Title: Detection of venous thromboembolic diseases by measurement of D-dimers and soluble fibrin levels
Inventor: MIRSHAHI BIBI SHAH SOLTAN
IPC: G01N33/86
Filed: 2007-05-03
Granted: 2012-12-13
Abstract: This application concerns a process and a test for the detection of the activation of coagulation, particularly when it is responsible for venous thromboembolic diseases, using the measurement of the levels of D-dimers and soluble fibrin produced during a fibrin lysis process activated in a blood sample. The method according to the invention is based on the comparison of levels of D-dimers which corresponds to the degradation of soluble fibrin and the level of D-dimers in the sample, with normal threshold values. The test of the invention can also be used to determine if anticoagulation in a patient is sufficient.
Patent AU-2008201865-B2 (AU)
Title: Alternating processing method, system, and computer program product
Inventor: ALEXANDROS FOUNTOUKAS
IPC: G06Q30/00
Filed: 2008-04-29
Granted: 2011-07-28
Abstract: -36 Abstract Among other things, processing an incoming message stream includes storing context data of an application in a global database. Various messages from the incoming message stream are placed in an in-memory message queue. One of at 5 least a first and a second phases at a first process is executed, and another of the at least first and second phases at a second process is also executed, so as to alternately execute a first phase and a second phase by a first process and a second process. The first phase includes processing at least one message from the various messages and storing at least one corresponding result in a local memory area. The first phase also 10 includes storing at least one modification to the context data in the local memory area. The second phase includes performing a transaction of the at least one result and the at least one modification of the context data to the global database and committing the transaction. 23/04/08,kn 17146 specification,36 Abstract Among other things, processing an incoming message stream includes storing context data of an application in a global database. Various messages from the incoming message stream are placed in an in-memory message queue. One of at 5 least a first and a second phases at a first process is executed, and another of the at least first and second phases at a second process is also executed, so as to alternately execute a first phase and a second phase by a first process and a second process. The first phase includes processing at least one message from the various messages and storing at least one corresponding result in a local memory area. The first phase also 10 includes storing at least one modification to the context data in the local memory area. The second phase includes performing a transaction of the at least one result and the at least one modification of the context data to the global database and committing the transaction. 23/04/08,kn 17146 specification,36
Patent AU-2008203166-B2 (AU)
Title: Systems and methods for thermally profiling radiofrequency electrodes
Inventor: PODHAJSKY RONALD J
IPC: A61N1/06
Filed: 2008-07-16
Granted: 2012-08-23
Abstract: SYSTEMS AND METHODS FOR THERMALLY PROFILING RADIOFREQUENCY Systems and methods for providing radiofrequency ("RF") energy to a target surgical site are provided. The systems include the use of at least one overlay (202) which is super-imposed over an image of the target surgical site to assist the operator in evaluating parameters for performing the surgical procedure. The disclosure also include methods for creating at least one overlay (202) and for using an overlay (202) in surgical procedures using RF energy. 102 NV p 106 ,,200 Z @ @ T --------- \202\-202n
Patent AU-2008203373-B2 (AU)
Title: Nuclear fertility restorer genes and methods of use in plants
Inventor: LANDRY BENOIT S
IPC: C12N15/29
Filed: 2008-07-29
Granted: 2012-04-05
Abstract: The present invention includes nuclear fertility restorer genes, proteins encoded by those genes and transgenic plants and plant cells containing those genes. More particularly, the nuclear fertility restorer genes can be used to restore fertility in cytoplasmic male-sterile plants such as Brassica napus. Preferably, the nuclear fertility restorer genes are used with the Ogura (ogu) CMS system in Brassica napus.
Patent AU-2008205278-B2 (AU)
Title: Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same
Inventor: JANKOWSKI RONALD
IPC: A61K35/12
Filed: 2008-01-11
Granted: 2014-06-12
Abstract: The present invention provides muscle-derived progenitor cells that show long-term survival following transplantation into body tissues and which can augment soft tissue following introduction (e.g. via injection, transplantation, or implantation) into a site of soft tissue. Also provided are methods of isolating muscle-derived progenitor cells, and methods of genetically modifying the cells for gene transfer therapy. The invention further provides methods of using compositions comprising muscle-derived progenitor cells for the augmentation and bulking of mammalian, including human, soft tissues in the treatment of various functional conditions, including malformation, injury, weakness, disease, or dysfunction. In particular, the present invention provides treatments and amelioration for urinary incontinence and other urinary tract pathologies.
Patent AU-2008237543-B2 (AU)
Title: Medical device flexible conduit and method of manufacture
Inventor: KRULEVITCH PETER
IPC: A61M39/00
Filed: 2008-10-27
Granted: 2013-06-06
Abstract: -16 METHOD FOR INSERTING A MEDICAL DEVICE FLEXIBLE CONDUIT INTO A USER'S TARGET SITE A method for inserting a medical device flexible conduit into a user's target 10 site includes adhering a medical device to a user with the medical device including a medical device flexible conduit and an insertion mechanism. Moreover, the medical device flexible conduit has an elongated Nitinol strip with a distal end, a proximal end, a longitudinal axis running from the distal end to the proximal end, a sharp head extending from the distal end, and a channel etched therein. In addition, the channel 15 is dispositioned along the longitudinal axis. The medical device flexible conduit also includes a flexible tube at least partially jacketing the elongated Nitinol strip between the distal end and the proximal end, the channel and flexible tube defining a conduit. The insertion mechanism is configured to insert a portion of the flexible conduit including the sharp head into a user's target site such that the conduit provides fluid 20 communication to the target site. The method also includes inserting the medical device flexible conduit into the user's target site. 17/10/08,va 17572 speci,16
Patent AU-2008310605-B2 (AU)
Title: Methods of culturing lawsonia intracellularis
Inventor: STRIETZEL CATHERINE J
IPC: C12N1/20
Filed: 2008-10-14
Granted: 2013-05-30
Abstract: The present invention relates generally to the growth of Lawsonia intracellularis in non-mammalian cells and the production of the bacteria on a large scale.
Patent AU-2008336247-B2 (AU)
Title: Cyclic, cystein-free protein
Inventor: FISCHER BERNHARD
IPC: A61K38/19
Filed: 2008-12-12
Granted: 2012-10-25
Abstract: The invention relates to a protein which is selected from the amino acid sequence of the region valine Val(91) to glycine Gly(121) of the mature, human tumor necrosis factor, or a part thereof, provided that the protein comprises at least the amino acid sequence of the region lysine Lys(98) to glutamic acid Glu(116), the cysteine Cys(101) being replaced by a glycine and an amide bond being formed between the amino group of the side chain of the lysine Lys(98) and the carboxyl group of the side chain of the glutamic acid Glu(116). The protein activates epithelial ion channels and improves the pulmonary function and can be used to produce drugs for the treatment of diseases that are associated with the pulmonary function, such as oedema.
Patent AU-2009201825-B2 (AU)
Title: Rail anchor isolator for railroad tie
Inventor: REED MARTIN EARL
IPC: E01B13/02
Filed: 2009-05-07
Granted: 2014-09-04
Abstract: RAIL ANCHOR ISOLATOR FOR RAILROAD TIE 5 The present invention provides an isolator (10) particularly adapted for use with a rail anchor (50) utilized in an application where railroad rail (42) is installed on concrete ties (40). The isolator (10) protects the concrete tie (40) from contact with the rail anchor (50) caused by longitudinal movement of the rail (42) due to train acceleration of deceleration or expansion and contraction due to temperature changes. In one io embodiment, the isolator (10) is comprised of a structural plastic material and includes a front face section (12) and a rear face section (23). The front face section (12) and rear face section (23) each comprise a generally rectangular structure, having a top edge, bottom edge, and side edges. Top and bottom sections (20, 13) join the front face section (12) and rear face section (23) and form part of the isolator (10). The rail anchor (50) also is comprises a support section (24) that extends from an intersection of the rear face section (23) with the bottom section (13). The rail isolator (10) is designed to be embedded in a concrete railroad tie (40). Fig. I 21 46 f-!5 5 12 1324 56 13 56 10 -44 33
Patent AU-2009218902-B2 (AU)
Title: Wood composition containing olefins, use of olefins for rendering raw wood materials water repellent, and method for the production of wood materials
Inventor: BUCHHOLZ THOMAS
IPC: B27N3/00
Filed: 2009-02-25
Granted: 2013-08-15
Abstract: The invention relates to a wood composition containing olefin and raw wood materials, the use of said olefins for rendering raw wood materials water repellent, and a method for producing wood materials therefrom. The raw wood materials contain or are made of lignocellulose and are provided in the form of fibers, strands, or chips.
Patent AU-2009249221-B2 (AU)
Title: Medical system having a medical unit and a display monitor
Inventor: NIKLEWSKI PAUL J
IPC: G16H20/17
Filed: 2009-05-19
Granted: 2015-09-03
Abstract: A medical system includes a display monitor and a medical unit. The medical unit is adapted to measure a physiological parameter of a patient. The medical unit is adapted to wirelessly connect to the display monitor, wherein the display monitor is adapted to display the physiological parameter. In one implementation of the medical system, the medical unit is adapted to automatically wirelessly connect to the display monitor when the medical unit is brought into proximity with the display monitor. In one illustration of the medical system, the physiological parameter is a pulse rate of the patient.